Abstract:CRISPR-Cas systems are functionally diverse prokaryotic antiviral defense systems, which encompass six distinct types (I–VI) that each encode different effector Cas nucleases with distinct nucleic acid cleavage specificities. By harnessing the unique attributes of the various CRISPR-Cas systems, a range of innovative CRISPR-based DNA and RNA targeting tools and technologies have been developed. Here, we exploit the ability of type III-A CRISPR-Cas systems to carry out RNA-guided and sequence-specific target RNA cleavage for establishment of research tools for post-transcriptional control of gene expression. Type III-A systems from three bacterial species ( L. lactis , S. epidermidis , and S. thermophilus ) were each expressed on a single plasmid in E. coli , and the efficiency and specificity of gene knockdown was assessed by northern blot and transcriptomic analysis. We show that engineered type III-A modules can be programmed using tailored CRISPR RNAs to efficiently knock down gene expression of both coding and noncoding RNAs in vivo. Moreover, simultaneous degradation of multiple cellular mRNA transcripts can be directed by utilizing a CRISPR array expressing corresponding gene-targeting crRNAs. Our results demonstrate the utility of distinct type III-A modules to serve as specific and effective gene knockdown platforms in heterologous cells. This transcriptome engineering technology has the potential to be further refined and exploited for key applications including gene discovery and gene pathway analyses in additional prokaryotic and perhaps eukaryotic cells and organisms.

Repurposing endogenous type I CRISPR-Cas systems for programmable gene repression

Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system

Type III-A CRISPR systems as a versatile gene knockdown technology

CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes

CRISPR Interference (crispri) for Sequence-Specific Control of Gene Expression

An enhanced CRISPR repressor for targeted mammalian gene regulation

CRISPRe: An innate transcriptional enhancer for endogenous genes in CRISPR-Cas immunity

Reprogramming CRISPR-Mediated RNA Interference for Silencing of Essential Genes in Sulfolobales

Programmable RNA targeting with the single-protein CRISPR effector Cas7-11

crRNA complementarity shifts endogenous CRISPR-Cas systems between transcriptional repression and DNA defense

Exploiting activation and inactivation mechanisms in type I-C CRISPR-Cas3 for genome-editing applications

Gene Repression in Haloarchaea Using the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats)-Cas I-B System

Multiplex gene regulation by CRISPR-ddCpf1

Endogenous Gene Regulation as a Predicted Main Function of Type I-E CRISPR/Cas System in E. coli

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation

Native CRISPR-Cas-based programmable multiplex gene repression in Klebsiella variicola

Cas11 enables genome engineering in human cells with compact CRISPR-Cas3 systems

Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors

Functional characterization of diverse type I-F CRISPR-associated transposons